Clinical Trial Update: Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (ACHIEVE) is evaluating chemotherapy plus immunotherapy versus immunotherapy alone in older adults with stage IIIB-IV non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 | Phase 3 | Status: RECRUITING